Sahpra's Glp-1 Crackdown Exposes A Trust Crisis In South Africa's Longevity Industry
As regulators move against unregistered GLP-1 and GIP medicines, NADclinic South Africa says the next phase of longevity medicine must be built on clinical governance, diagnostics, transparency an…
